Brenntag, the global market leader in chemicals and ingredients distribution, today announced a new exclusive distribution agreement with BiCT, a leading European biotechnology company. This collaboration introduces Lactive, an innovative, award-winning skincare ingredient that is a sustainable and effective alternative to synthetic formulations, to the Beauty & Personal Care industries in Iberia and Italy.
Lactive is the bioactivated form of lactoferrin, a natural milk protein with antimicrobial, anti-inflammatory and wound-healing properties. It helps to rebalance the skin’s microbiome and is therefore ideal for acne-prone skin. It strengthens the skin barrier for skin prone to atopic dermatitis and prevents skin aging by promoting regeneration and resilience.
Alessandra Gozzi, Sales Manager Personal Care Europe South – Brenntag Specialties Beauty & Personal Care EMEA, remarked: “With Lactive, our customers can offer consumers a highly effective, science-backed ingredient that naturally enhances skin health. By strengthening the skin barrier, soothing irritation, and providing antimicrobial protection, Lactive allows skincare companies to formulate products that deliver visible, long-lasting benefits. This innovation not only meets consumer demand for bioactive ingredients but also helps our customers stand out in a competitive market.”
Silvia Rapacioli, General Manager at BiCT, added: “Lactive stands as a game-changing bioactive ingredient, empowering brands to create skincare solutions. With BiCT’s new collaboration with Brenntag, this innovation will reach even more markets, enabling tailored formulations and expert-driven solutions that set brands apart in the competitive beauty industry. Together, we are shaping the future of skincare with science-backed, high-performance ingredients.”
